High Court Told Not To Review Lilly's $20M Cialis Patent Loss
A company that Eli Lilly has called "shadowy" has urged the U.S. Supreme Court not to hear the pharmaceutical giant's appeal of a $20 million loss over its Cialis drug, while...To view the full article, register now.
Already a subscriber? Click here to view full article